688256.SHG

For Cambricon Technologies to rerate higher, Net Profit Attributable to Shareholders for Q3 2026 needs to demonstrate strong year-over-year growth, ideally exceeding the 122.61% growth reported in H1 2026. Given the bullish sentiment in the Chinese AI compute sector and recent positive full-year net income growth revisions (up to 190% for fiscal year 2026), a Q3 2026 Net Profit Attributable to Shareholders growth rate of at least 150% year-over-year, or an absolute net profit figure significantly above the previous quarter's (Q2 2026) 1.30 billion CNY, would be a strong catalyst.

Achieving robust growth in Net Profit Attributable to Shareholders validates Cambricon's execution within China's strategic AI self-sufficiency drive. It signals effective monetization of AI chip demand and R&D investments, reinforcing the long thesis and competitive position. This performance would exceed market expectations, potentially driving a positive rerating by demonstrating sustained profitability and growth in a critical industry.

For Cambricon Technologies to rerate higher, its Gross Profit Margin for the upcoming 2026-10-24 earnings report needs to exceed 50.02% (its trailing twelve-month gross margin) and ideally approach or surpass 55%. This would demonstrate continued margin expansion driven by strong AI chip demand and effective pricing strategies, outperforming recent peer gross margins like SMIC's 25.3% and Hua Hong's 16.5%.

A Gross Profit Margin above 50.02% signals Cambricon's strong pricing power and operational efficiency in the booming Chinese AI chip market. This validates the long thesis of AI-driven demand and domestic substitution, indicating robust profitability and a competitive edge crucial for a positive rerating.

Total Revenue for Q3 2026 needs to hit at least 8.59 billion CNY, representing a beat of 5% or more above the current analyst consensus estimate of 8.178 billion CNY.

A significant revenue beat would demonstrate Cambricon's strong execution and ability to capitalize on robust AI chip demand and China's domestic substitution drive. This would validate the investment thesis, signal market share gains, and could lead to upward revisions in future estimates, driving a positive stock rerating.